PRESS RELEASE published on 09/20/2024 at 14:54, 1 year 9 months ago Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc The Vanguard Group, Inc. discloses a 4.91% stake in Smith (DS) plc while making disclosures related to International Paper Company. Purchase of 10p ordinary securities at 4.85 GBP per unit Vanguard Group Stake Disclosure Securities Purchase Smith DS Plc International Paper
PRESS RELEASE published on 09/20/2024 at 14:53, 1 year 9 months ago Form 8.3 - The Vanguard Group, Inc.: REA Group Ltd The Vanguard Group, Inc. discloses 2.08% stake in REA Group Ltd. Dealing disclosure includes purchases of ordinary shares at AUD 198.00 and AUD 199.69 per unit on 19th September 2024 Ordinary Shares Vanguard Group Stake Disclosure Purchases REA Group Ltd
BRIEF published on 09/19/2024 at 15:19, 1 year 9 months ago The Vanguard Group Discloses Position in International Paper Company Securities Form 8.3 Stake Vanguard International Paper
BRIEF published on 09/19/2024 at 15:18, 1 year 9 months ago The Vanguard Group, Inc. Discloses Position in Centamin plc Securities Disclosure Takeover Code Vanguard Centamin
BRIEF published on 09/19/2024 at 15:17, 1 year 9 months ago The Vanguard Group, Inc. Discloses Position in Balanced Commercial Property Trust Limited Form 8.3 Takeover Code Vanguard Group Disclosures Balanced Commercial Property
BRIEF published on 09/19/2024 at 15:15, 1 year 9 months ago The Vanguard Group Discloses Interests in TI Fluid Systems plc Form 8.3 Securities Disclosure Vanguard Group Shareholding TI Fluid Systems
PRESS RELEASE published on 09/19/2024 at 15:14, 1 year 9 months ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company The Vanguard Group, Inc. discloses a stake in International Paper Company as per Form 8.3 submission. Disclosure includes ownership of 11.84% common stock Form 8.3 Vanguard Group Common Stock Stake Disclosure International Paper Company
BRIEF published on 09/19/2024 at 15:14, 1 year 9 months ago Vanguard Group Discloses Significant Stake in AngloGold Ashanti Securities Disclosure Vanguard Group Stake AngloGold Ashanti
PRESS RELEASE published on 09/19/2024 at 15:13, 1 year 9 months ago Form 8.3 - The Vanguard Group, Inc.: Centamin plc The Vanguard Group, Inc. disclosed a 5.33% stake in Centamin plc on 18 September 2024. Additional disclosures related to AngloGold Ashanti plc The Vanguard Group, Inc. Financial Disclosure Stake Disclosure Centamin Plc AngloGold Ashanti Plc
BRIEF published on 09/19/2024 at 15:13, 1 year 9 months ago The Vanguard Group Discloses Position in Ascential plc Form 8.3 Takeover Code Vanguard Group Stock Disclosure Ascential Plc
Published on 06/30/2026 at 15:00, 2 hours 26 minutes ago Four Nines Gold Advances Toward Maiden Drill Program with Property-Wide Geophysical Survey at Hayden Hill
Published on 06/30/2026 at 15:00, 2 hours 26 minutes ago BlackBerry AtHoc Strengthens Enterprise Readiness as Cyber, Climate, and Geopolitical Uncertainty Rises
Published on 06/30/2026 at 15:00, 2 hours 26 minutes ago Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF)
Published on 06/30/2026 at 14:30, 2 hours 56 minutes ago NV Gold Announces Non-Brokered Private Placement
Published on 06/30/2026 at 14:00, 3 hours 26 minutes ago Datametrex Announces Completion of AI-Based Evaluation of 2 Patents and Launch of Licensing Initiative
Published on 06/30/2026 at 16:34, 51 minutes ago hep global concludes fiscal year 2025 with a positive consolidated result
Published on 06/30/2026 at 16:05, 1 hour 20 minutes ago Selective PPARα Modulator "K-808" (Pemafibrate) Granted "Breakthrough Therapy" Designation by the U.S. Food and Drug Administration (FDA) As a Treatment for Primary Biliary Cholangitis
Published on 06/30/2026 at 07:30, 9 hours 56 minutes ago Gimv sells its stake in AlpenBlu Clinics (formerly Les Psy Réunis), a Swiss provider of outpatient mental healthcare, to Impact Healthcare.
Published on 06/30/2026 at 07:00, 10 hours 26 minutes ago bioMérieux submits 510(k) to U.S. FDA for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens
Published on 06/29/2026 at 18:30, 22 hours 56 minutes ago Accor and H World Group expand long-term partnership across direct booking and loyalty platforms